DRREDDYNSEDr. Reddy's Laboratories Limited· PharmaceuticalsHighNegative
Announced Tue, 17 Mar · 17:24 IST

Dr. Reddy's Laboratories Limited has informed the Exchange about Action(s) taken or orders passed

Regulatory & Legal View source PDF

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹1281.90
prior close
₹1283.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.5+0.7+0.7-0.1+1.1-2.6-2.0+2.0-2.3-3.7-4.0+3.8-0.8
Up moveDown movePending
AI summary

Dr. Reddy's Laboratories has received three orders from the Commercial Tax Department in Chennai under the Tamil Nadu GST Act, 2017, covering FY 2019-20 to FY 2021-22. The total penalty demanded is approximately ₹2.20 crore, broken down as ₹2.19 crore for FY 2019-20, ₹50,406 for FY 2020-21, and ₹4,384 for FY 2021-22. The authority held that certain supplies made by the company are taxable. The company has stated there is no material impact on its financials, operations, or other activities, and plans to file an appeal with the appellate authority.

Likely market impact

The financial impact is minor and the company has confirmed it is not material, so shareholders are unlikely to see any meaningful effect on earnings or stock price. The planned appeal could further reduce or nullify the demand.